Popular Weight-Loss Drugs Produce Less Weight Loss in Real-World Settings, Study Finds
Patients with obesity who take GLP-1 receptor agonists in real-world settings lose significantly less weight than participants in randomized clinical trials, according to new research.
Health News is provided as a service to Diabetes Resource Centre site users by HealthDay. Diabetes Resource Centre nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.